Literature DB >> 22246539

Impact of lamina closure on long-term outcomes of open-door laminoplasty in patients with cervical myelopathy: minimum 5-year follow-up study.

Morio Matsumoto1, Kota Watanabe, Naobumi Hosogane, Takashi Tsuji, Ken Ishii, Masaya Nakamura, Kazuhiro Chiba, Yoshiaki Toyama.   

Abstract

STUDY
DESIGN: A prospective follow-up study.
OBJECTIVE: To elucidate the impact of lamina closure on long-term outcomes after open-door laminoplasty. SUMMARY OF BACKGROUND DATA: In a previous study, we did not find significant associations between lamina closure and short-term outcomes. METHODS.: Of the original cohort of 82 patients who underwent open-door laminoplasty, 69 were included in this study (52 men, 17 women; mean age, 60.9 yr; mean follow-up, 6.2 yr; 56 with spondylosis or disc herniation, 13 with ossification of posterior longitudinal ligament). Lamina closure was previously observed in 23 of these patients (closure group) but not in 46 (nonclosure group). The Japanese Orthopaedic Association (JOA) scores and Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire were recorded.
RESULTS: The JOA score was 9.9 ± 3.2 in the closure group and 11.2 ± 2.3 in the nonclosure group before surgery (P = 0.1), 13.8 ± 2.3 and 13.8 ± 2.2 at 1.8 years (P = 0.99), and 13.6 ± 2.2 and 14.2 ± 2.7 at final follow-up (P = 0.29). The recovery rate of the JOA scores was 56.7 ± 30.0% and 46.7 ± 29.2% at 1.8 years (P = 0.22) and 51.0 ± 32.5 and 57.6 ± 31.1 at the final follow-up (P = 0.42). The subdomains assessed by the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire at follow-up were cervical spine function, 68.7 ± 27.5 in the closure group and 67.7 ± 30.0 in the nonclosure group (P = 0.93); upper extremity function, 78.6 ± 24.3 and 87.6 ± 15.4 (P = 0.40); lower extremity function, 69.9 ± 26.0 and 73.9 ± 22.5 (P = 0.68); bladder function, 74.6 ± 22.6 and 84.9 ± 29.2 (P = 0.18); and quality of life, 53.9 ± 25.3 and 56.2 ± 18.1 (P = 0.96).
CONCLUSION: Lamina closure did not significantly impact the long-term surgical outcomes of laminoplasty for cervical myelopathy. Although not statistically significant, the recovery rate tended to decline in the closure group compared with the nonclosure group during the long-term follow-up period, and the utilization of a laminar retention device to prevent the laminar closure should be considered.

Entities:  

Mesh:

Year:  2012        PMID: 22246539     DOI: 10.1097/BRS.0b013e3182498434

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  14 in total

1.  Double-door cervical laminoplasty with suture anchors: evaluation of the clinical performance of the constructs.

Authors:  Takashi Fujishiro; Atsushi Nakano; Ichiro Baba; Shingo Fukumoto; Yoshiharu Nakaya; Masashi Neo
Journal:  Eur Spine J       Date:  2016-06-21       Impact factor: 3.134

2.  Relationship between the laminoplasty opening size and the laminoplasty opening angle, increased sagittal canal diameter and the prediction of spinal canal expansion following open-door cervical laminoplasty.

Authors:  Zhenfang Gu; Aili Zhang; Yong Shen; Feng Li; Xianze Sun; Wenyuan Ding
Journal:  Eur Spine J       Date:  2015-01-28       Impact factor: 3.134

3.  Extraordinary positional cervical spinal cord compression in extension position as a rare cause of postoperative progressive myelopathy after cervical posterior laminoplasty detected using the extension/flexion positional CT myelography: one case after laminectomy following failure of a single-door laminoplasty/one case after double-door laminoplasty without interlaminar spacers.

Authors:  Yasushi Fujiwara; Hideki Manabe; Takahiro Harada; Bunichiro Izumi; Nobuo Adachi
Journal:  Eur Spine J       Date:  2017-02-28       Impact factor: 3.134

4.  Modified Open-Door Laminoplasty Using a Ceramic Spacer and Suture Fixation for Cervical Myelopathy.

Authors:  Tomoyuki Ozawa; Tomoaki Toyone; Ryutaro Shiboi; Kunimasa Inada; Yasuhiro Oikawa; Kazuhisa Takahashi; Seiji Ohtori; Gen Inoue; Masayuki Miyagi; Tetsuhiro Ishikawa; Toshiyuki Shirahata; Yoshifumi Kudo; Katsunori Inagaki
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

5.  Laminar closure rates in patients with cervical myelopathies treated with either open-door laminoplasty with reattachment of spinous processes and extensor musculature or Hirabayashi open-door laminoplasty: a case-control study.

Authors:  Kentaro Yamane; Yoshihisa Sugimoto; Masato Tanaka; Shinya Arataki; Tomoyuki Takigawa; Toshifumi Ozaki
Journal:  Eur Spine J       Date:  2016-01-28       Impact factor: 3.134

6.  Expansive open-door laminoplasty secured with titanium miniplates is a good surgical method for multiple-level cervical stenosis.

Authors:  Kuang-Ting Yeh; Tzai-Chiu Yu; Ing-Ho Chen; Cheng-Huan Peng; Kuan-Lin Liu; Ru-Ping Lee; Wen-Tien Wu
Journal:  J Orthop Surg Res       Date:  2014-08-21       Impact factor: 2.359

7.  Risk factor analysis of hinge fusion failure after plate-only open-door laminoplasty.

Authors:  Sungjoon Lee; Chun Kee Chung; Chi Heon Kim
Journal:  Global Spine J       Date:  2014-10-10

8.  Relationship of actual laminoplasty opening size and increment of the cross-sectional area based on single-door cervical laminoplasy.

Authors:  Xiao-Jiang Yang; Rui-Jun Tian; Xing Su; Shan-Bo Hu; Wei Lei; Yang Zhang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

9.  The Midterm Surgical Outcome of Modified Expansive Open-Door Laminoplasty.

Authors:  Kuang-Ting Yeh; Ru-Ping Lee; Ing-Ho Chen; Tzai-Chiu Yu; Cheng-Huan Peng; Kuan-Lin Liu; Jen-Hung Wang; Wen-Tien Wu
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

10.  Long-term outcomes and prognostic analysis of modified open-door laminoplasty with lateral mass screw fusion in treatment of cervical spondylotic myelopathy.

Authors:  Nan Su; Qi Fei; Bingqiang Wang; Dong Li; Jinjun Li; Hai Meng; Yong Yang; Ai Guo
Journal:  Ther Clin Risk Manag       Date:  2016-08-31       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.